Fig. 5From: The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivoa. Percentage of neutrophils in the BALF after OVA challenge. b. Number of neutrophils in the BALF after OVA challenge. c. Percentage of neutrophils in the BALF after OVA sensitization and challenge. d. Number of neutrophils in the BALF after OVA sensitization and challenge. See legend to Fig. 3 . In A and B, (*) and (***) P < 0.05 and P < 0.001 vs. PBS alone; (++) P < 0.01 vs. rutile NP; (#) and (###) P < 0.05 and P < 0.001 vs. anatase NP. In C and D, (**) P < 0.01 vs. OVA alone; (++) P < 0.01 vs. OVA + rutile NP; (#) P < 0.05 vs. OVA + anatase NPBack to article page